CRVS — Corvus Pharmaceuticals, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1626971 ·
Last close
$10.17
Market Cap
$857.87M
52W High
$26.95
52W Low
$6.39
ADV30
1,036,776
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -21,362,000 -20,343,000 223,878,000 15,013,000 15,557,000
Jun 2026 0 — -19,297,000 -17,959,000 239,274,000 18,905,000 13,946,000
Mar 2026 0 — -14,877,000 -13,692,000 253,195,000 40,102,000 12,516,000
Dec 2025 0 — -12,217,000 -12,321,000 71,119,000 4,576,000 9,914,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-44,529,000
Investing CF
$-142,549,000
Financing CF
$191,292,000
CapEx
$-811,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.61
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-443,944,000
Inventory
—
Receivables
$1,849,000
ST Investments
$196,323,000
EBIT TTM
$-56,963,000
Pretax Income TTM
$-54,129,000
Interest Exp TTM
—
Analysts
6

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -42,971,000 -15,283,000 71,119,000 9,914,000 61,205,000 -32,797,000
Dec 2024 0 -27,548,000 -62,293,000 68,907,000 36,339,000 32,568,000 -25,424,000
Dec 2023 0 -23,407,000 -27,029,000 45,553,000 6,869,000 38,684,000 -23,935,000
Dec 2022 0 -32,565,000 -41,307,000 68,240,000 12,125,000 56,115,000 -27,023,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-54,129,000
OpCashFlow TTM
—
Assets (Latest)
$239,274,000
Forward EPS
$-1.07

Max Pain — expiry 2028-01-21

max pain strike: $20.00 · spot: $10.19 · call oi: 0 · put oi: 1,627
Expected Move to 2028-01-21: ±$9.90 (97.15%) — implied range $0.29 – $20.09 · ATM straddle on $10.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PHAR Pharming Group N.V. $853.58M $12.06 —
CTY CITY THERAPEUTICS, INC. $846.44M $17.50 —
AKTS Aktis Oncology, Inc. $879.52M $16.31 —
ORIC Oric Pharmaceuticals, Inc. $829.22M $8.00 —
SNDX Syndax Pharmaceuticals Inc $828.26M $9.20 —

News headlines (Yahoo Finance, 1h cache)

Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference in London
2026-11-09 21:05 · Yahoo
Corvus (CRVS) Q3 2026 Earnings Call Transcript
2026-11-06 17:05 · Yahoo
Corvus Pharmaceuticals Inc (CRVS) Q3 2026 Earnings Call Highlights: Strong Cash Runway and Key ...
2026-11-06 15:15 · Yahoo
Corvus Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
What Corvus Pharmaceuticals (CRVS) Said on Its Q3 Earnings Call
2026-11-05 23:14 · Yahoo
Corvus: Q3 Earnings Snapshot
2026-11-05 21:36 · Yahoo
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2026 Financial Results
2026-11-05 21:01 · Yahoo
Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hemato
2026-11-04 14:01 · Yahoo
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026
2026-10-29 12:00 · Yahoo
Corvus Pharmaceuticals (CRVS) Faces A Valuation Test, Is The Upside Already Priced In?
2026-09-25 14:09 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.